WELIREG®▼ (belzutifan) Patient Diary
Prescribing Information [External link]
Patient treatment diary for the support of patients that have been prescribed WELIREG. This diary is also accessible on the patient support website www.welireg.co.uk and can be ordered as a printed booklet upon request by clicking the option above or emailing msdukoncology@msd.com.
WELIREG is indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for VHL associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumours (pNET), and for whom localised procedures are unsuitable or undesirable.
For more information on WELIREG visit the product page:
